Investors were initially cheered on Wednesday, sending the shares over Rs313 in early trading, but they are heading back down to Rs306, where they started the day.
Let’s pick it apart. Read more
Indian markets have been upbeat of late. Investors appear to have put concerns over liquidity and EM currencies behind them, while many expect a stable government to emerge after this year’s general election.
As the country’s earnings season begins on Friday the upbeat mood is expected to continue, with analysts at Bank of America Merrill Lynch expecting profits to rise 22 per cent year-on-year for Sensex listed companies on a consolidated basis. Read more
Second quarter numbers from India’s largest bank by assets, State Bank of India (SBI), were announced on Wednesday – and despite weak profits the markets are still cheering.
As the economy slows and companies suffer, the focus for India’s public sector banks is firmly on asset quality. Read more
Shares in Apollo Tyres opened up more than 3 per cent on Tuesday at Rs76.90, adding to a gain of 4 per cent on Monday.
The stock is enjoying a nice run this week, having lost some 15 per cent since June 12, when the Indian group announced plans to acquire Cooper Tire and Rubber in a $2.5bn deal set to be the largest takeover of a US group for India. Read more
Cut out Jaguar Land Rover, the luxury British carmaker Tata Motors acquired back in 2008, and the Indian group is unrecognisable.
In the three months to September, Tata Motors made a loss after tax of Rs8bn ($128m) on a standalone basis – down from a profit of Rs8.7bn in the same period last year. Read more
Shares in Jet Airways fell as much as 6.4 per cent on Thursday morning before making a partial recovery, after the group reported its worst quarterly figures on record, according to Thomson Reuters.
The group posted a net loss of Rs8.9bn ($145m) in the quarter ended in September, almost nine times its loss a year earlier, just as Etihad Airways prepares to take a 24 per cent stake in the airline. Read more
In the past month, shares in Infosys have risen 21.1 per cent and Tata Consultancy Services has rallied 22.7 per cent. Meanwhile, shares in Wipro, India’s third largest IT company, have gained a relatively meagre 9.8 per cent.
The company’s results, out on Friday, followed positive figures from India’s other two IT giants. And comments from management suggest Wipro is ready to play catch-up. Read more
After the Bernanke boost, it’s Infosys’s turn. India’s benchmark Nifty index opened up 1.1 per cent at 6,000.50 on Friday, having gained 2 per cent in the previous session on rumblings from the Federal Reserve, as Infosys set the earnings season off to a good start.
Buy now, pay later – a common retail policy. That looks like the explanation behind Chilean retailer Cencosud’s 63 per cent fall in first quarter net profits.
The purchase in question was the $2.6bn acquisition of Carrefour in Colombia, which beyondbrics noted at the time raised questions about the price tag involved, for which it took out a $2.5bn loan with J.P. Morgan Chase. Read more
No wonder then that government-controlled Banco do Brasil is turning to the international debt markets for help. Read more
The shoe industry in Brazil has been going through a difficult moment but not for all manufacturers. It is not hard to figure which one has been doing well. Just walk down the street in São Paulo and see what type of shoes people are wearing – those cool ones made from rubber are likely to be from Brazilian manufacturer Grendene’s “Jelly” range. The remainder? Probably Chinese. Read more
As news broke Tuesday that the Mexican government was postponing its long awaited banking-reform bill for political reasons, the country’s biggest domestically-owned bank was preparing to report a tidy 27 per cent rise in first-quarter profits.
Banorte, Mexico’s third-biggest lender and the largest domestic bank in a sector dominated by foreign names, said that profits climbed between January and the end of March to 3.1bn pesos ($253m). It didn’t give the peso figure for the comparable quarter of 2012. Read more
After acquiring a small French company last week, Tata Consultancy Services (TCS) says it is looking to make further acquisitions in Germany and Japan.
The plans were mentioned during a press conference after the Indian IT bellwether published its full-year earnings report, meeting expectations and confirming that the highly disappointing results posted by Infosys last week were not indicative of the state of India’s broader IT services sector. Read more
In January, unexpectedly positive results from Infosys sent the company’s stock soaring and set the tone for a good run of quarterly earnings for India’s information technology sector.
One quarter later and Infosys has kicked off the full fiscal year earnings season with news that has sent its share price plunging right back to where it used to be. Is this, once again, a sign of what’s to come? Read more
2012 was a tough year for Gol, Brazil’s second-biggest airline. The company went through a series of job cuts, suffered net losses and was subject to rumours that it was about to be sold. The latter proved unfounded but what has not changed is that Gol’s financial results continue to disappoint. Read more
Take your time, China – it’s only almost April. The 2012 results season for the nation’s biggest banks is finally upon us. China’s second-largest lender kicked things off this week, reporting a 14 per cent increase in net income. This sounds good, but it is China Construction Bank’s lowest income growth in six years. That is what happens when Beijing liberalises interest rates, removing fat interest margins for state banks. Net interest margin fell 5 basis points over the last three months of 2012 at CCB. Other banks will surely have seen similar falls.
Shares in Indian generic drugs group Ranbaxy Laboratories dropped 4.2 per cent on Wednesday to Rs399.20, having lost 4 per cent in the previous session, after the company posted disappointing financial results.
The numbers caused analysts to question the company’s expenses and launch of new drugs, given the performance. Read more
|About this blog||Commenting|